Treatment of Orthostatic Intolerance

Sponsor
Satish R. Raj (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT00262470
Collaborator
National Institutes of Health (NIH) (NIH)
150
1
20
344
0.4

Study Details

Study Description

Brief Summary

This trial is designed to study the effects of various mechanistically unique medications in controlling excessive increases in heart rate with standing and in improving the symptoms of orthostatic intolerance in patients with this disorder.

Condition or Disease Intervention/Treatment Phase
Phase 1/Phase 2

Study Design

Study Type:
Interventional
Anticipated Enrollment :
150 participants
Allocation:
Non-Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Treatment of Orthostatic Intolerance
Actual Study Start Date :
Apr 1, 1997
Anticipated Primary Completion Date :
Dec 1, 2025
Anticipated Study Completion Date :
Dec 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

Acetazolamide

Drug: Acetazolamide
250 mg PO x 1
Other Names:
  • Diamox
  • Experimental: 2

    Atomoxetine

    Drug: Atomoxetine
    10-40 mg PO x 1 dose
    Other Names:
  • Strattera
  • Drug: Atomoxetine & Propranolol
    Atomoxetine 10-40 mg PO x 1 dose AND propranolol 20 mg PO x 1 dose
    Other Names:
  • Strattera
  • Inderal
  • Experimental: 3

    NO Drug

    Other: NO Drug
    No intervention - just monitoring

    Experimental: 4

    Clonidine

    Drug: Clonidine
    Clonidine 0.05-0.3 mg PO x 1 dose
    Other Names:
  • Catapres
  • Experimental: 5

    Entacapone

    Drug: Entacapone
    Entacapone 200-400 mg PO x 1 dose
    Other Names:
  • Comtan
  • Drug: Entacapone & Propranolol
    Entacapone 200-400 mg PO x 1 dose AND propranolol 20 mg PO x 1 dose
    Other Names:
  • Comtan
  • Inderal
  • Experimental: 6

    Indomethacin

    Drug: Indomethacin
    Indomethacin 25-50 mg PO x 1 dose
    Other Names:
  • Indocin
  • Experimental: 7

    Isosorbide Dinitrate

    Drug: Isosorbide Dinitrate
    Isosorbide dinitrate 5-20 mg PO x 1 dose
    Other Names:
  • Isordil
  • Experimental: 8

    Mecamylamine

    Drug: Mecamylamine
    mecamylamine 1.25-5 mg PO x 1 dose
    Other Names:
  • inversine
  • Experimental: 9

    Memantine

    Drug: memantine
    memantine 5-20 mg PO x 1 dose
    Other Names:
  • Namenda
  • Experimental: 10

    Melatonin

    Dietary Supplement: Melatonin
    melatonin 3 mg PO x 1 dose

    Experimental: 11

    Midodrine

    Drug: Midodrine
    midodrine 2.5-10 mg PO x 1 dose
    Other Names:
  • pro-amatine
  • Experimental: 12

    Modafinil

    Drug: Modafinil
    modafinil 100-200 mg PO x 1 dose
    Other Names:
  • provigil
  • Drug: Modafinil & Propranolol
    Modafinil 100-200 mg PO x 1 dose AND Propranolol 20 mg PO x 1 dose
    Other Names:
  • Provigil
  • Inderal
  • Experimental: 13

    Octreotide

    Drug: Octreotide
    octreotide 12.5-50 mcg Subcutaneous x 1 dose
    Other Names:
  • sandostatin
  • Placebo Comparator: 14

    Placebo (lactose tablet)

    Radiation: Placebo
    lactose tablet x 1 pill

    Experimental: 15

    Propranolol

    Drug: Entacapone & Propranolol
    Entacapone 200-400 mg PO x 1 dose AND propranolol 20 mg PO x 1 dose
    Other Names:
  • Comtan
  • Inderal
  • Drug: Atomoxetine & Propranolol
    Atomoxetine 10-40 mg PO x 1 dose AND propranolol 20 mg PO x 1 dose
    Other Names:
  • Strattera
  • Inderal
  • Drug: Propranolol
    Propranolol 10-80 mg PO x 1-2 dose
    Other Names:
  • Inderal
  • Drug: Modafinil & Propranolol
    Modafinil 100-200 mg PO x 1 dose AND Propranolol 20 mg PO x 1 dose
    Other Names:
  • Provigil
  • Inderal
  • Experimental: 16

    Sertraline

    Drug: Sertraline
    sertraline 25-50 mg PO x 1 dose
    Other Names:
  • Zoloft
  • Experimental: 17

    Normal Saline (0.9%) 1 liter

    Procedure: IV Saline
    1 liter IV over 2 hours
    Other Names:
  • NaCl solution (0.9%)
  • Experimental: 18

    Drinking Water

    Other: Drinking Water
    16 fluid ounces

    Experimental: 19

    Dead Space Breathing Device

    Device: Breathing Device
    Breathing through a dead space tube

    Experimental: Abdominal Binder

    Abdominal binder with inflatable pressure over abdomen

    Device: Abdominal binder
    Using large blood pressure cuffs linked together, they are wrapped around the subjects abdomen and inflated to generate increased pressure to below tolerably threshold.

    Outcome Measures

    Primary Outcome Measures

    1. Increase in heart rate with standing [1-4 hours]

    Secondary Outcome Measures

    1. Sitting heart rate [1-4 hours]

    2. Standing heart rate [1-4 hours]

    3. Blood pressure [1-4 hours]

    4. Decrease in blood pressure with standing [1-4 hours]

    5. Orthostatic symptoms score [Baseline, 2h, 4h]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Chronic symptoms (> 6 months) with standing upright
    Exclusion Criteria:
    • Obvious cause of hypovolemia or drugs that could worsen tachycardia

    • Chronic severe medical conditions such as cancer or ischemic heart disease

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Vanderbilt University Autonomic Dysfunction Center Nashville Tennessee United States 37232-2195

    Sponsors and Collaborators

    • Satish R. Raj
    • National Institutes of Health (NIH)

    Investigators

    • Principal Investigator: Satish R Raj, MD MSCI, Vanderbilt University School of Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Satish R. Raj, Assistant Professor of Medicine & Pharmacology, Vanderbilt University
    ClinicalTrials.gov Identifier:
    NCT00262470
    Other Study ID Numbers:
    • 008397
    • UL1TR000445
    First Posted:
    Dec 6, 2005
    Last Update Posted:
    Sep 8, 2021
    Last Verified:
    Sep 1, 2021

    Study Results

    No Results Posted as of Sep 8, 2021